Integrated Filing — IndAS


General information about company

Scrip Code 544309
NSE Symbol IKS
MSEI Symbol NOTLISTED
ISIN INE115Q01022
Name of company INVENTURUS KNOWLEDGE SOLUTIONS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 15-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 23-Apr-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment CARE ENABLEMENT PLATFORM PROVIDING TECHNOLOGY ENABLED SOLUTIONS TO HEALTHCARE PROVIDERS
Start date and time of board meeting 15-May-2025   19:20:00
End date and time of board meeting 15-May-2025   20:35:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 7239560000 26639940000
Other income 32610000 389980000
Total income 7272170000 27029920000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 0 0
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0 7470000
(d) Employee benefit expense 3865500000 14946060000
(e) Finance costs 210190000 897650000
(f) Depreciation, depletion and amortisation expense 283330000 1126630000
(f) Other Expenses
1 Other expenses 1112300000 3989290000
Total other expenses 1112300000 3989290000
Total expenses 5471320000 20967100000
3 Total profit before exceptional items and tax 1800850000 6062820000
4 Exceptional items 0 0
5 Total profit before tax 1800850000 6062820000
6 Tax expense
7 Current tax 163970000 1247550000
8 Deferred tax 158860000 -45320000
9 Total tax expenses 322830000 1202230000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 1478020000 4860590000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 1478020000 4860590000
17 Other comprehensive income net of taxes 629750000 681610000
18 Total Comprehensive Income for the period 2107770000 5542200000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 170230000 170230000
Face value of equity share capital 0 0
27 Details of debt securities
22 Reserves excluding revaluation reserve 17726700000
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 8.88 29.2
Diluted earnings (loss) per share from continuing operations 8.7 28.62
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 8.88 29.2
Diluted earnings (loss) per share from continuing and discontinued operations 8.7 28.62
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Notes to the Statement of Audited Consolidated and Standalone Financial Results for the year ended March 31 2025 n nThe above standalone financial results of Inventurus Knowledge Solutions Limited and consolidated financial results of the Company and its subsidiaries collectively the Group for the quarter and year ended March 31 2025 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in its meeting held on May 15 2025 The above results for the year ended March 31 2025 have been audited by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBl Listing Obligations and Disclosure Requirements Regulations 2015 as amended The figures for the quarter ended March 31 2024 as reported in the statement have been approved by the Companys Board of Directors but have not been subjected to limited review since the requirement of submission of quarterly financial results is applicable on listing of equity shares of the Company from the quarter ended December 31 2024 n nThe statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder.t n nThe figures of the quarter ended March 31 2025 and March 31 2024 are balancing figure between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the respective financial years n nThe Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers This in the context of Indian Accounting Standard Operating Segments constitutes a single operating segment n nThe Company has allotted 464800 shares previous period 123398 shares for the quarter and 648002 shares previous year 852798 shares for the year ended March 31 2025 on exercise of Employee Stock options Accordingly the Company has transferred Rs 106.18 million to the Securities Premium during the year ended March 31 2025 n nThe Board at their meeting held on April 22 2022 approved the 2022 Plan for issue of shares or options to key employees of the Company and its subsidiaries. During the quarter and year ended March 31 2025 the Company has granted Nil and 3699840 stock options respectively to eligible employees as approved in the Nomination and Remuneration Committee meeting The related share based compensation expense for the quarter and year ended March 31 2025 is Rs 110.05 million and Rs 277.31 million respectively n nEarnings per share for the interim periods are not annualised n nThe consolidated financial results of the Group include the results of its subsidiary companies viz Inventurus Knowledge Solutions Inc, IKS Cares Foundation and its step down subsidiary companies viz: Aquity Holdings Inc Aquity Solutions LLC Aquity Solutions India Private Limited Aquity Solutions Australia Pty Limited and Aquity Canada ULC n nThe figures appearing in the year ended March 31 2024 of the consolidated financial results includes figures of Aquity Holdings Inc acquired on October 27 2023 and hence are not comparable with the March 31 2025 presented above



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 412420000
Capital work-in-progress 53420000
Investment property
Goodwill 11972630000
Other intangible assets 5515460000
Intangible assets under development 77090000
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 1137370000
Trade receivables, non-current 216540000
Loans, non-current 0
Other non-current financial assets 1114370000
Total non-current financial assets 2468280000
Deferred tax assets (net) 1859930000
Other non-current assets 320440000
Total non-current assets 22679670000
2 Current assets
Inventories 0
Current financial asset
Current investments 0
Trade receivables, current 5320590000
Cash and cash equivalents 1804220000
Bank balance other than cash and cash equivalents 118820000
Loans, current 0
Other current financial assets 263690000
Total current financial assets 7507320000
Current tax assets (net)
Other current assets 331390000
Total current assets 7838710000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 30518380000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 170230000
Other equity 17726700000
Total equity attributable to owners of parent 17896930000
Non controlling interest 0
Total equity 17896930000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 5092720000
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities 774590000
Total non-current financial liabilities 5867310000
Provisions, non-current 200850000
Deferred tax liabilities (net) 1324910000
Deferred government grants, Non-current 0
Other non-current liabilities 16610000
Total non-current liabilities 7409680000
Current liabilities
Current financial liabilities
Borrowings, current 2457670000
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 14190000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 745370000
Total Trade payable 759560000
Other current financial liabilities 303850000
Total current financial liabilities 3521080000
Other current liabilities 1010540000
Provisions, current 514380000
Current tax liabilities (Net) 165770000
Deferred government grants, Current 0
Total current liabilities 5211770000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 12621450000
Total equity and liabilites 30518380000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) Not Applicable refere note 4 of the Statement of audited financial results for the quarter and financial year ended March 31 2025



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of post employment benefit obligations -2440000 -18150000
2 Changes in the fair value of equity investments at FVOCI 689350000 691400000
Total Amount of items that will not be reclassified to profit and loss 686910000 673250000
2 Income tax relating to items that will not be reclassified to profit or loss 178720000 176690000
3 Amount of items that will be reclassified to profit and loss
1 Gains/ (losses) on cash flow hedges (net) 179930000 -39420000
2 Exchange differences on translation of financial statements of foreign operations -30600000 217590000
Total Amount of items that will be reclassified to profit and loss 149330000 178170000
4 Income tax relating to items that will be reclassified to profit or loss 27770000 -6880000
5 Total Other comprehensive income 629750000 681610000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 6062820000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 897650000
Adjustments for decrease (increase) in inventories 7570000
Adjustments for decrease (increase) in trade receivables, current -2034840000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets -84450000
Adjustments for decrease (increase) in other non-current assets -88980000
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current 0
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 326910000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities -5440000
Adjustments for increase (decrease) in other non-current liabilities -477640000
Adjustments for depreciation and amortisation expense 1126630000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current -166360000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current -1187300000
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains 4560000
Adjustments for dividend income 0
Adjustments for interest income 129450000
Adjustments for share-based payments 277310000
Adjustments for fair value losses (gains) 17470000
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items -206160000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -1722520000
Net cash flows from (used in) operations 4340300000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 1161420000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities 3178880000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 644490000
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 5140000
Purchase of property, plant and equipment 246910000
Proceeds from sales of investment property 1514710000
Purchase of investment property 0
Proceeds from sales of intangible assets 0
Purchase of intangible assets 176870000
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 261510000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 1731400000
Net cash flows from (used in) investing activities 2444490000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 667830000
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 229550000
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 3281310000
Payments of lease liabilities 317660000
Dividends paid 0
Interest paid 734160000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities -3894850000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 1728520000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents -32140000
Net increase (decrease) in cash and cash equivalents 1696380000
Cash and cash equivalents cash flow statement at beginning of period -234830000
Cash and cash equivalents cash flow statement at end of period 1461550000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Price Waterhouse Chartered Accountants LLP Yes 30-Nov-2026


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income
2 Total Expenditure
3 Net Profit/(Loss)
4 Earnings Per Share
5 Total Assets
6 Total Liabilities
7 Net Worth




Signatories detail

Name of CEO / Managing director
Name of CFO
Name of audit committee chairman
Name of statutory auditor
Name of other signatory, if any, with designation
Place
Date